Page 70 - MemoriaBBN-Eng

RESEARCH GROUPS

í

í
á
íé

á
á
öú
ñ

ñ

á

PROGRAMME:
Translational Research Group in
Biomaterials and
Biomaterials and Tissue Engineering
Tissue Engineering
ó

Group Members
Lead Researcher

íBelln Caneiro, Juan Manuel
STAFF MEMBERS
Martnez-Alcocer Fuerte, Soraya

Pascual Gonzlez, Ma Gemma
Contact:
Dpto. de Ciruga ASSOCIATED MEMBERS
Bujn Varela, Julia
Facultad de Medicina. Universidad de Alcalá de Henares.
Campus Univ. Ctra. Madrid-Barcelona, km. 33,6. Cifuentes Negrete, Alberto

Phone: (+34) 91 885 45 40 · E-mail: [email protected] Garca Honduvilla, Natalio
https://portal.uah.es/portal/page/portal/grupos_de_investigacion/57/Presentacion
Gonzlez Chamorro, Diana

CONTRIBUTORS

Prez Khler, Brbara Main lines of research
Rodrguez Mancheo, Marta

Sotomayor Nez, Sandra
• BIOMATERIALS FOR THE REPAIR OF ABDOMINAL WALL DEFECTS. This re-

search has the purpose of repairing damaged and/or missing tissues mainly
located in the abdominal wall. Several types of biomaterials for clinical use

have been used in this line as supports, new designs and modifications the-
reof being developed. Different collagen bioprostheses as well as composites
meshes and prosthetic materials with polymeric coatings that can reduce in-

flammation, accelerate healing process or prevent contamination are currently
being assayed.
13
20
• REPAIR OF SKIN DEFECTS. One of the alternatives for the repair of skin de- T
R
fects, especially in patients with compromised healing (diabetics, torpid vas- PO
cular ulcers and pressure ulcers) can be improved through tissue engineering E
L R
strategies. Essentially work is being conducted with two experimental models: A
muscle-derived stem cells for repairing excisional skin defects with encoura- NU
N
ging results, and the design of polymers for the controlled release of healing A
modulating drugs.
/
BN
• VASCULAR REPAIR. Work has been conducted within this line in healing/ B
R-
restenosis, with special interest in the modulation thereof, concluding that BE
intimal hyperplasia is a result of the vascular wall healing process, which has CI

70
the objective of maintaining homeostasis of the damaged vessel. The problem
of arterial substitution by means of biomaterials for clinical use and cryopre-